Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Sales | 6,809 | 3,129 | 1,229 | 1,118 | 0 |
| Gross Profit | 6,809 | 3,129 | 1,229 | 1,118 | N/A |
| Operating Expenses | 152,587 | 90,932 | 30,236 | 17,086 | 0 |
| Operating Income | -145,778 | -87,803 | -29,007 | -15,968 | N/A |
| Interest Expense | 0 | 861 | 2,130 | 770 | 0 |
| Other Income | 4,026 | -1,531 | -2 | 9 | 0 |
| Pre-tax Income | -141,752 | -90,195 | -31,139 | -16,729 | 0 |
| Net Income Continuous | -141,752 | -90,195 | -31,139 | -16,729 | N/A |
| Net Income Discontinuous | N/A | N/A | -5,999 | -12,994 | N/A |
| Net Income | $-141,752 | $-90,195 | $-37,138 | $-29,723 | $N/A |
| EPS Basic Total Ops | -3.49 | -2.88 | -24.78 | -26.47 | N/A |
| EPS Basic Continuous Ops | -3.49 | -2.88 | -20.78 | -14.90 | N/A |
| EPS Basic Discontinuous Ops | N/A | N/A | -4.00 | -11.57 | N/A |
| EPS Diluted Total Ops | -3.49 | -2.88 | -24.78 | -26.47 | N/A |
| EPS Diluted Continuous Ops | -3.49 | -2.88 | -20.78 | -14.90 | N/A |
| EPS Diluted Discontinuous Ops | N/A | N/A | -4.00 | -11.57 | N/A |
| EPS Diluted Before Non-Recurring Items | -3.49 | -2.88 | N/A | N/A | N/A |
| EBITDA(a) | $-147,831 | $-87,545 | $-28,898 | $-15,933 | $N/A |